SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001019056-14-000351
Filing Date
2014-03-10
Accepted
2014-03-10 07:34:36
Documents
1
Group Members
AL FRIEDBERGFCMI FIN CORPPAN ATL B&T LIM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A bioline_13da5.htm SC 13D/A 106615
  Complete submission text file 0001019056-14-000351.txt   108220
Mailing Address BCE PLACE 181 BAY STREET SUITE 250 TORONTO CANADA A6
Business Address BCE PLACE 181 BAY STREET SUITE 250 TORONTO CANADA A6
FCMI FINANCIAL CORP ET AL (Filed by) CIK: 0000931301 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Subject) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86614 | Film No.: 14679108
SIC: 2834 Pharmaceutical Preparations